Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer … – Nasdaq
|
Therapeutic Solutions International Launches Multi-Protocol Cancer Immunotherapy Clinical Trial with Pan Am Cancer …
Nasdaq NanoStilbene, a nanoparticle formulation of pterostilbene is covered for use in cancer immunotherapy under the Company’s issued U.S. Patent No.: 9,682,047. Pterostilbene is the active ingredient in the Company’s patented ProJuvenol product. StemVacs is … |
Seeking Alpha |
3 Things In Biotech, April 30: Another ADC, Another Breakthrough, Another Immunotherapy
Seeking Alpha Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious. Welcome to another edition of “3 Things In … |
9&10 News |
There’s a problem with stem cell therapy in Florida | Florida Trend …
Florida Trend Medical experts warn the diseased and desperate are now targets of a booming new stem cell industry in Florida promising better health. Across Florida, stem cell clinics – popping up like med spas – are offering sick and diseased patients treatments … Healthy Living: Stem Cell Therapy – 9 & 10 News9&10 News |